{"pmid":32305487,"pmcid":"PMC7162743","title":"Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui, China.","text":["Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui, China.","J Infect","Wei, Yuan-Yuan","Wang, Rui-Rui","Zhang, Da-Wei","Tu, You-Hui","Chen, Chang-Shan","Ji, Shuang","Li, Chun-Xi","Li, Xiu-Yong","Zhou, Meng-Xi","Cao, Wen-Sheng","Han, Ming-Feng","Fei, Guang-He","32305487"],"journal":"J Infect","authors":["Wei, Yuan-Yuan","Wang, Rui-Rui","Zhang, Da-Wei","Tu, You-Hui","Chen, Chang-Shan","Ji, Shuang","Li, Chun-Xi","Li, Xiu-Yong","Zhou, Meng-Xi","Cao, Wen-Sheng","Han, Ming-Feng","Fei, Guang-He"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305487","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jinf.2020.04.010","source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"locations":["Anhui","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664641855693783040,"score":8.518259,"similar":[{"pmid":32289565,"pmcid":"PMC7151431","title":"Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China.","text":["Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China.","OBJECTIVE: To investigate the epidemiological and clinical features of patients with COVID-19 in Anhui province of China. METHOD: In this descriptive study, we obtained epidemiological, demographic, manifestations, laboratory data and radiological findings of patients confirmed by real-time RT-PCR in the NO.2 People's Hospital of Fuyang City from Jan 20 to Feb 9, 2020. Clinical outcomes were followed up to Feb 18, 2020. RESULTS: Of 125 patients infected SARS-CoV-2, the mean age was 38.76 years (SD, 13.799) and 71(56.8%) were male. Common symptoms include fever [116 (92.8%)], cough [102(81.6%)], and shortness of breath [57(45.6%)]. Lymphocytopenia developed in 48(38.4%) patients. 100(80.0%) patients showed bilateral pneumonia, 26(20.8%) patients showed multiple mottling and ground-glass opacity. All patients were given antiviral therapy. 19(15.2%) patients were transferred to the intensive care unit. By February 18, 47(37.6%) patients were discharged and none of patients died. Among the discharged patients, the median time of length of stay was 14.8 days (SD 4.16). CONCLUSION: In this single-center, retrospective, descriptive study, fever is the most common symptom. Old age, chronic underlying diseases and smoking history may be risk factors to worse condition. Certain laboratory inspection may contribute to the judgment of the severity of illness.","Int J Infect Dis","Wang, Ruirui","Pan, Min","Zhang, Xiumei","Fan, Xiaoyun","Han, Mingfeng","Zhao, Fengde","Miao, Manli","Xu, Jing","Guan, Minglong","Deng, Xia","Chen, Xu","Shen, Leilei","32289565"],"abstract":["OBJECTIVE: To investigate the epidemiological and clinical features of patients with COVID-19 in Anhui province of China. METHOD: In this descriptive study, we obtained epidemiological, demographic, manifestations, laboratory data and radiological findings of patients confirmed by real-time RT-PCR in the NO.2 People's Hospital of Fuyang City from Jan 20 to Feb 9, 2020. Clinical outcomes were followed up to Feb 18, 2020. RESULTS: Of 125 patients infected SARS-CoV-2, the mean age was 38.76 years (SD, 13.799) and 71(56.8%) were male. Common symptoms include fever [116 (92.8%)], cough [102(81.6%)], and shortness of breath [57(45.6%)]. Lymphocytopenia developed in 48(38.4%) patients. 100(80.0%) patients showed bilateral pneumonia, 26(20.8%) patients showed multiple mottling and ground-glass opacity. All patients were given antiviral therapy. 19(15.2%) patients were transferred to the intensive care unit. By February 18, 47(37.6%) patients were discharged and none of patients died. Among the discharged patients, the median time of length of stay was 14.8 days (SD 4.16). CONCLUSION: In this single-center, retrospective, descriptive study, fever is the most common symptom. Old age, chronic underlying diseases and smoking history may be risk factors to worse condition. Certain laboratory inspection may contribute to the judgment of the severity of illness."],"journal":"Int J Infect Dis","authors":["Wang, Ruirui","Pan, Min","Zhang, Xiumei","Fan, Xiaoyun","Han, Mingfeng","Zhao, Fengde","Miao, Manli","Xu, Jing","Guan, Minglong","Deng, Xia","Chen, Xu","Shen, Leilei"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32289565","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.ijid.2020.03.070","keywords":["anhui province","covid-19","clinical features","epidemiological"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Anhui","China","Lymphocytopenia","Fuyang","Anhui","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664636391673298944,"score":77.03848},{"pmid":32328736,"title":"No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity.","text":["No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity.","Clin Res Cardiol","Li, Gerui","Li, Hang","Lu, Jinping","32328736"],"journal":"Clin Res Cardiol","authors":["Li, Gerui","Li, Hang","Lu, Jinping"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32328736","week":"202017|Apr 20 - Apr 26","doi":"10.1007/s00392-020-01653-6","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664996914929598464,"score":71.28405},{"pmid":32304772,"pmcid":"PMC7158802","title":"Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China.","text":["Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China.","BACKGROUND: The novel coronavirus disease 2019 (COVID-19) has become a global health emergency. Cumulative number of new confirmed case and death are still increasing out of China. However, the independent predicted factors associated with the fatal outcome remain uncertain. METHODS: A retrospective cohort of 1590 hospitalized subjects with COVID-19 throughout China was established. The prognostic effects of variables, including clinical features and laboratory findings, were analyzed using Kapla-Meier method and Cox proportional hazard model. A prognostic nomogram was formulated to predict the survival of patient with COVID-19. RESULTS: In this nationwide cohort, non-survivors showed higher incidence of elderly people, subjects with co-existing chronic illness, dyspnea and laboratory abnormalities on admission, compared with survivors. Multivariate Cox regression analysis showed that age>/=75 (HR: 7.86, 95% CI: 2.44-25.35), age between 65-74 years (HR:3.43, 95%CI: 1.24-9.5), coronary heart disease (HR:4.28, 95%CI:1.14-16.13), cerebrovascular disease(HR:3.1, 95%CI:1.07-8.94), dyspnea (HR: 3.96, 95%CI:1.42-11), procalcitonin>0.5ng/ml(HR:8.72, 95%CI:3.42-22.28), aspartate aminotransferase>40U/liter (HR: 2.2, 95% CI: 1.1- 6.73) were independent risk factors associated with fatal outcome. A nomogram was established based on the results of multivariate analysis. The internal bootstrap resampling approach suggested the nomogram has sufficient discriminatory power with the C-index of 0.91 (95%CI 0.85-0.97). The calibration plots also demonstrated good consistence between the prediction and the observation. CONCLUSIONS: The proposed nomogram accurately predict clinical outcomes of patients with COVID-19 based on individual characteristics. Earlier identification, more intensive surveillance and appropriate therapy should be considered in patients with high risk.","Chest","Chen, Ruchong","Liang, Wenhua","Jiang, Mei","Guan, Weijie","Zhan, Chen","Wang, Tao","Tang, Chunli","Sang, Ling","Liu, Jiaxing","Ni, Zhengyi","Hu, Yu","Liu, Lei","Shan, Hong","Lei, Chunliang","Peng, Yixiang","Wei, Li","Liu, Yong","Hu, Yahua","Peng, Peng","Wang, Jianming","Liu, Jiyang","Chen, Zhong","Li, Gang","Zheng, Zhijian","Qiu, Shaoqin","Luo, Jie","Ye, Changjiang","Zhu, Shaoyong","Liu, Xiaoqing","Cheng, Linling","Ye, Feng","Zheng, Jinping","Zhang, Nuofu","Li, Yimin","He, Jianxing","Li, Shiyue","Zhong, Nanshan","32304772"],"abstract":["BACKGROUND: The novel coronavirus disease 2019 (COVID-19) has become a global health emergency. Cumulative number of new confirmed case and death are still increasing out of China. However, the independent predicted factors associated with the fatal outcome remain uncertain. METHODS: A retrospective cohort of 1590 hospitalized subjects with COVID-19 throughout China was established. The prognostic effects of variables, including clinical features and laboratory findings, were analyzed using Kapla-Meier method and Cox proportional hazard model. A prognostic nomogram was formulated to predict the survival of patient with COVID-19. RESULTS: In this nationwide cohort, non-survivors showed higher incidence of elderly people, subjects with co-existing chronic illness, dyspnea and laboratory abnormalities on admission, compared with survivors. Multivariate Cox regression analysis showed that age>/=75 (HR: 7.86, 95% CI: 2.44-25.35), age between 65-74 years (HR:3.43, 95%CI: 1.24-9.5), coronary heart disease (HR:4.28, 95%CI:1.14-16.13), cerebrovascular disease(HR:3.1, 95%CI:1.07-8.94), dyspnea (HR: 3.96, 95%CI:1.42-11), procalcitonin>0.5ng/ml(HR:8.72, 95%CI:3.42-22.28), aspartate aminotransferase>40U/liter (HR: 2.2, 95% CI: 1.1- 6.73) were independent risk factors associated with fatal outcome. A nomogram was established based on the results of multivariate analysis. The internal bootstrap resampling approach suggested the nomogram has sufficient discriminatory power with the C-index of 0.91 (95%CI 0.85-0.97). The calibration plots also demonstrated good consistence between the prediction and the observation. CONCLUSIONS: The proposed nomogram accurately predict clinical outcomes of patients with COVID-19 based on individual characteristics. Earlier identification, more intensive surveillance and appropriate therapy should be considered in patients with high risk."],"journal":"Chest","authors":["Chen, Ruchong","Liang, Wenhua","Jiang, Mei","Guan, Weijie","Zhan, Chen","Wang, Tao","Tang, Chunli","Sang, Ling","Liu, Jiaxing","Ni, Zhengyi","Hu, Yu","Liu, Lei","Shan, Hong","Lei, Chunliang","Peng, Yixiang","Wei, Li","Liu, Yong","Hu, Yahua","Peng, Peng","Wang, Jianming","Liu, Jiyang","Chen, Zhong","Li, Gang","Zheng, Zhijian","Qiu, Shaoqin","Luo, Jie","Ye, Changjiang","Zhu, Shaoyong","Liu, Xiaoqing","Cheng, Linling","Ye, Feng","Zheng, Jinping","Zhang, Nuofu","Li, Yimin","He, Jianxing","Li, Shiyue","Zhong, Nanshan"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32304772","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.chest.2020.04.010","keywords":["covid-19","fatal outcome","nomogram","risk factors"],"source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"locations":["China","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664632934650347520,"score":70.6912},{"pmid":32305490,"pmcid":"PMC7162771","title":"Risk Factors Associated with Disease Severity and Length of Hospital Stay in COVID-19 Patients.","text":["Risk Factors Associated with Disease Severity and Length of Hospital Stay in COVID-19 Patients.","J Infect","Liu, Xiaofan","Zhou, Hong","Zhou, Yilu","Wu, Xiaojun","Zhao, Yang","Lu, Yang","Tan, Weijun","Yuan, Mingli","Ding, Xuhong","Zou, Jinjing","Li, Ruiyun","Liu, Hailing","Ewing, Rob M","Hu, Yi","Nie, Hanxiang","Wang, Yihua","32305490"],"journal":"J Infect","authors":["Liu, Xiaofan","Zhou, Hong","Zhou, Yilu","Wu, Xiaojun","Zhao, Yang","Lu, Yang","Tan, Weijun","Yuan, Mingli","Ding, Xuhong","Zou, Jinjing","Li, Ruiyun","Liu, Hailing","Ewing, Rob M","Hu, Yi","Nie, Hanxiang","Wang, Yihua"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305490","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jinf.2020.04.008","source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664641855749357568,"score":70.42797},{"pmid":32320741,"title":"Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.","text":["Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.","BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) has been declared a pandemic in 2020. Patients with metabolic associated fatty liver disease (MAFLD) are often obese and have additional metabolic risk factors which may aggravate the severity of respiratory diseases and of COVID-19. This study aims to investigate the association between MAFLD and COVID-19 severity. METHODS: 214 patients with laboratory-confirmed COVID-19 aged between 18 and 75years from three hospitals in Wenzhou, China were consecutively enrolled. Sixty-six patients with MAFLD were included in the final analysis. COVID-19 was diagnosed as a positive result by high-throughput sequencing or real-time reverse transcriptase-polymerase chain reaction assay of oropharyngeal swab specimens. COVID-19 severity was assessed during hospitalization and classified as severe and non-severe based on the current management guideline. All patients were screened for fatty liver by computed tomography and subsequently diagnosed as MAFLD according to a recent set of consensus diagnostic criteria. Obesity was defined as BMI >25kg/m(2). RESULTS: The presence of obesity in MAFLD patients was associated with a~6-fold increased risk of severe COVID-19 illness (unadjusted-OR 5.77, 95% CI 1.19-27.91, p=.029). Notably, this association with obesity and COVID-19 severity remained significant (adjusted-OR 6.32, 95% CI 1.16-34.54, p=.033) even after adjusting for age, sex, smoking, diabetes, hypertension, and dyslipidaemia. CONCLUSIONS: Our data demonstrate that the risk of obesity to COVID-19 severity is greater in those with, than those without MAFLD.","Metabolism","Zheng, Kenneth I","Gao, Feng","Wang, Xiao-Bo","Sun, Qing-Feng","Pan, Ke-Hua","Wang, Ting-Yao","Ma, Hong-Lei","Liu, Wen-Yue","George, Jacob","Zheng, Ming-Hua","32320741"],"abstract":["BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) has been declared a pandemic in 2020. Patients with metabolic associated fatty liver disease (MAFLD) are often obese and have additional metabolic risk factors which may aggravate the severity of respiratory diseases and of COVID-19. This study aims to investigate the association between MAFLD and COVID-19 severity. METHODS: 214 patients with laboratory-confirmed COVID-19 aged between 18 and 75years from three hospitals in Wenzhou, China were consecutively enrolled. Sixty-six patients with MAFLD were included in the final analysis. COVID-19 was diagnosed as a positive result by high-throughput sequencing or real-time reverse transcriptase-polymerase chain reaction assay of oropharyngeal swab specimens. COVID-19 severity was assessed during hospitalization and classified as severe and non-severe based on the current management guideline. All patients were screened for fatty liver by computed tomography and subsequently diagnosed as MAFLD according to a recent set of consensus diagnostic criteria. Obesity was defined as BMI >25kg/m(2). RESULTS: The presence of obesity in MAFLD patients was associated with a~6-fold increased risk of severe COVID-19 illness (unadjusted-OR 5.77, 95% CI 1.19-27.91, p=.029). Notably, this association with obesity and COVID-19 severity remained significant (adjusted-OR 6.32, 95% CI 1.16-34.54, p=.033) even after adjusting for age, sex, smoking, diabetes, hypertension, and dyslipidaemia. CONCLUSIONS: Our data demonstrate that the risk of obesity to COVID-19 severity is greater in those with, than those without MAFLD."],"journal":"Metabolism","authors":["Zheng, Kenneth I","Gao, Feng","Wang, Xiao-Bo","Sun, Qing-Feng","Pan, Ke-Hua","Wang, Ting-Yao","Ma, Hong-Lei","Liu, Wen-Yue","George, Jacob","Zheng, Ming-Hua"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32320741","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.metabol.2020.154244","keywords":["covid-19","mafld","obesity","sars-cov-2"],"source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"locations":["obese","Wenzhou","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664815087808937986,"score":67.16926}]}